7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Meet Veristat at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
🔬 Advancing Clinical Research with Strategic Partnership
Veristat is proud to be attending SCOPE 2026, where industry leaders gather to shape the future of clinical trials, data strategy, and operational excellence. As the clinical development landscape evolves and expectations rise, our team is ready to forge new collaborations and share insights that accelerate progress and improve outcomes.
👥 Meet the Veristat Team at SCOPE
Connect with our experts to explore how Veristat’s tailored solutions can advance your clinical and regulatory milestones:
-
Kim Boerike, Chief Operating Officer
-
AJ Mills, Vice President, Global Commercial
-
Caroline Hyde, Business Development Manager
-
Ryan Butcher, Team Lead, Account Development
📅 Schedule a meeting in advance
By completing the form on this page. We welcome the opportunity to discuss your upcoming programs and how Veristat can be a strategic partner in your success.
💡 Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Let’s shape the future of clinical research—together.
Schedule A Meeting
Meet with us at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...